Japanese encephalitis vaccine cost: a major reason to be vaccinated in Bali

2021 ◽  
Author(s):  
I Md Ady Wirawan
Keyword(s):  
Japanese Encephalitis ◽  
Home Country ◽  
Vaccine Cost ◽  
Japanese Encephalitis Vaccine ◽  
To Receive

Travellers, especially long term and repeat, are increasingly opting to receive vaccines in destination countries. This report summarizes the high cost of Japanese encephalitis vaccination in their home country as a barrier to pre-travel uptake.

Long-term immunity and immune response to a booster dose following vaccination with the inactivated Japanese encephalitis vaccine IXIARO®, IC51

Vaccine ◽  
2010 ◽  
Vol 28 (32) ◽  
pp. 5197-5202 ◽  
Author(s):  
Katrin Dubischar-Kastner ◽  
Susanne Eder ◽  
Vera Buerger ◽  
Gabriele Gartner-Woelfl ◽  
Astrid Kaltenboeck ◽  
...  
Keyword(s):  
Immune Response ◽  
Japanese Encephalitis ◽  
Booster Dose ◽  
Japanese Encephalitis Vaccine

scholarly journals Persistence of Immune Responses With an Inactivated Japanese Encephalitis Single-Dose Vaccine, JENVAC and Interchangeability With a Live-Attenuated Vaccine

2019 ◽  
Vol 222 (9) ◽  
pp. 1478-1487 ◽  
Author(s):  
Krishna Mohan Vadrevu ◽  
Venugopal Potula ◽  
Vasant Khalatkar ◽  
Niranjana S Mahantshetty ◽  
Atish Shah ◽  
...  
Keyword(s):  
Single Dose ◽  
Japanese Encephalitis ◽  
Healthy Children ◽  
Open Label ◽  
Live Attenuated Vaccine ◽  
Time Points ◽  
Japanese Encephalitis Vaccine ◽  
Randomized Control ◽  
To Receive ◽  
Dose Vaccine

Abstract Background This study reports immunogenicity, safety, and interchangeability of a single-dose, inactivated, Vero-cell derived, JENVAC to the live-attenuated SA 14-14-2 vaccine in healthy children. Methods This phase 4, multicenter, open-label, randomized, control trial enrolled 360 children who were equally randomized to receive a single dose of either JENVAC or SA 14-14-2. Children were followed at various time points, until 2 years (day 720) postvaccination, upon which a subset from each group was divided and allocated to a receive a booster dose or the other vaccine. Results At all time points, immunological measures were statistically higher in the JENVAC group. In the interchangeability study, children receiving 2 doses of JENVAC reported significantly higher response compared with 2 doses of SA 14-14-2. No difference in adverse events was observed. These corroborate with excellent seroprotection after the first dose of an earlier JENVAC study. Conclusions A single-dose vaccination with JENVAC induces protective titers that persist up to 1 year. We report appreciable interchangeability between both vaccines, with JENVAC/JENVAC combination exhibiting the highest immune response. JENVAC is now licensed as a single-dose Japanese encephalitis vaccine.

Long term immunity following a booster dose of the inactivated Japanese Encephalitis vaccine IXIARO®, IC51

Vaccine ◽  
2011 ◽  
Vol 29 (14) ◽  
pp. 2607-2612 ◽  
Author(s):  
Susanne Eder ◽  
Katrin Dubischar-Kastner ◽  
Christa Firbas ◽  
Tomas Jelinek ◽  
Bernd Jilma ◽  
...  
Keyword(s):  
Japanese Encephalitis ◽  
Booster Dose ◽  
Japanese Encephalitis Vaccine

scholarly journals Long term immunogenicity following a booster dose of the inactivated Japanese encephalitis vaccine IXIARO®, IC51

2010 ◽  
Vol 14 ◽  
pp. e449 ◽  
Author(s):  
K.L. Dubischar-Kastner ◽  
S. Eder ◽  
T. Jelinek ◽  
B. Jilma ◽  
A. Kaltenboeck ◽  
...  
Keyword(s):  
Japanese Encephalitis ◽  
Booster Dose ◽  
Japanese Encephalitis Vaccine

scholarly journals Long Term Follow up of the Lived Attenuated Japanese Encephalitis Vaccine (SA-14-14-2) Efficacy in Children of the four hyper-endemic Provinces of Northern Thailand, 2016.

2020 ◽  
Author(s):  
Narong Nitatpattana ◽  
Khajornpong Nakgoi ◽  
Sanjira Juntarapornchai ◽  
Sasiporn Ruangdachsuwan ◽  
Supot Ratchakum ◽  
...  
Keyword(s):  
Japanese Encephalitis ◽  
Neutralizing Antibodies ◽  
Seroconversion Rate ◽  
Neutralizing Antibody ◽  
Northern Region ◽  
Japanese Encephalitis Vaccine ◽  
Long Term Follow Up ◽  
One Year

Abstract Background. In Thailand, Japanese encephalitis appears with a higher incidence of the Northern region (0.0/100,000 cases/year) as compared to the central southern region of the country (0.01/100,000/year). Also, all Japanese encephalitis virus (JEV) recently isolated strains in country belong to the genotype I and III.Methods. In order to evaluate the long-term efficacy of the newly developed live attenuated SA 14-14-2 Japanese encephalitis vaccine in Thailand, the immune response in children was studied after a second immunization campaign. Following 2012 immunization campaign, a second JEV immunization vaccine was delivered to children among four provinces of the Northern Region of Thailand. For each province, the recipients were identified accordingly to the two vaccine campaigns time including the children who received the second dose of vaccine: 1/ less than one year before the present study (N=30 by province); 2/ more than one year before the present study (N=70 by province). Altogether, a total of 400 children were enrolled in this project. After receiving the second vaccine dose, blood samples were collected and tested for JEV (Genotypes I and III) neutralizing antibodies following a standard procedure of LLC-MK2 infected cells.Results. All recipient presented neutralizing antibodies cross reacting against the prevalent JEV genotypes I (SM1 JEV strain) and genotype III (SA 14-14-2 and Beijing JEV strains). Most of the children from the first group had a seroconversion rate of 94.2% against homologous (i.e. GIII). Among them, an optimal rate of 100% seroconversion was find at the Phayao Province against both heterologous (GI) and homologous (GIII) JEV strains. Geometric Mean Titer (GMT) of neutralizing antibody against SM1, SA 14-14-2 JEV, and Beijing JEV strains were consistently high, respectively as 239±50, 323±201.2 and 177±36.7. For the second group, seroconversion rate was lower against SM1, SA 14-14-2 and Beijing JEV strains with a rate of 94.3, 90% and 86.8% with respectively a GMT of 154±32, 90±23 and 82±13.6.Conclusion. Although, the immunity appears to decrease within the period of 2.5 years, neutralizing antibody rate are consistent to protect against the JEV infection. Nevertheless, a long-term follow up is suitable to evaluate an eventual third dose opportunity.

Effectiveness of a single dose of Japanese encephalitis vaccine among adults, Assam, India, 2012–2018

Vaccine ◽  
2021 ◽  
Author(s):  
Siraj A. Khan ◽  
Parveena Choudhury ◽  
Sanjeeb Kakati ◽  
Rimamoni Doley ◽  
Manash P. Barman ◽  
...  
Keyword(s):  
Single Dose ◽  
Japanese Encephalitis ◽  
Japanese Encephalitis Vaccine

Willingness of long‐term care staff to receive a COVID ‐19 vaccine: A single state survey

2020 ◽  
Author(s):  
Kathleen T. Unroe ◽  
Russell Evans ◽  
Lindsay Weaver ◽  
Dan Rusyniak ◽  
Justin Blackburn
Keyword(s):  
Long Term Care ◽  
Care Staff ◽  
Term Care ◽  
Single State ◽  
To Receive
Sign in / Sign up

Export Citation Format

Share Document